Skip to main content

Mycelex-3 Side Effects

Generic name: butoconazole topical

Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.

Note: This document provides detailed information about Mycelex-3.

Applies to butoconazole topical: intravaginal cream Side Effects associated with butoconazole topical. Some dosage forms listed on this page may not apply specifically to the brand name Mycelex-3.

Applies to butoconazole topical: intravaginal cream.

Side effects include:

Vulvar/vaginal burning, itching, soreness and swelling, pelvic or abdominal pain or cramping.

For healthcare professionals

Applies to butoconazole topical: vaginal cream.

Genitourinary

Local

Gastrointestinal

Nervous system

Hematologic

Thrombocytopenia developed 1 week after beginning this drug. It resolved slowly over the next few weeks after drug discontinuation.[Ref]

References

1. Ruf H, Vitse M (1990) "A comparison of butoconazole nitrate cream with econazole nitrate cream for the treatment of vulvovaginal candidiasis." J Int Med Res, 18, p. 389-99

2. Brown D Jr, Henzl MR, LePage ME, Tsao LL, Izu AE, Walker KA, Adamson GD, Droegmuller W (1986) "Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo." J Reprod Med, 31, p. 1045-8

3. (1986) "Butoconazole or vulvovaginal candidiasis." Med Lett Drugs Ther, 28, p. 68

4. (2022) "Product Information. Femstat (butoconazole topical)." Syntex Laboratories Inc

5. Maloley PA, Nelson E, Montgomery HA, Campbell JR (1990) "Severe reversible thrombocytopenia resulting from butoconazole cream." DICP, 24, p. 143-4

More about Mycelex-3 (butoconazole topical)

Patient resources

Other brands

Gynazole-1

Professional resources

Other brands

Gynazole-1

Other formulations

Related treatment guides

Further information

Mycelex-3 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.